Glenmark Pharma Q2 Review - Muted Show In India, U.S., Higher Interest Cost Drags Earnings: Motilal Oswal
3 weeks ago•Bloomberg Quint
Stocks To Watch: Coal India, ONGC, Glenmark Pharma, LIC, Grasim Industries, Eicher Motors, SAIL, Biocon
3 weeks ago•Bloomberg Quint
Glenmark Pharma Q2 Results: Incurs Loss Of Rs 62 Crore
4 weeks ago•Bloomberg Quint
Glenmark Pharma’s generic drug to treat psoriatic arthritis gets U.S. FDA approval
1 month ago•The Hindu
Glenmark Pharma’s Biotech Arm Licences Its Immunology Portfolio For Rs 2,700 Crore
1 month ago•Bloomberg Quint
Glenmark Pharma Shares Surge 10% On S&P Rating Outlook Upgrade
2 months ago•Bloomberg Quint
Glenmark Pharma Shares Fall As It Plans To Sell Life Sciences Business
2 months ago•Bloomberg Quint